Michelle Lockley

11PUBLICATIONS
65CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 02, 2026
Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.

|Apr 29, 2025
Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control.

Helen Hockings, Eszter Lakatos, Weini Huang

|Jan 14, 2025
Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer.

Uma Anne Mukherjee, Helen Hockings, Nicholas Counsell

|Oct 11, 2023
Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.

Lois B Travis, Darren R Feldman, Chunkit Fung

|May 15, 2023
Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis.

E H Puttock, E J Tyler, M Manni

|Nov 01, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.

Sue Philpott, Maria Raikou, Ranjit Manchanda

Pageof 2

Frequent Collaborators

3 joint publications

Iain McNeish

2 joint publications

Trevor Graham

2 joint publications

Helen Hockings

2 joint publications

Naveena Singh